InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has a beta of 1.34. The stock’s Relative Strength Index (RSI) is 55.24, with weekly volatility at 5.28% and ATR
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) previous close was $0.72 while the outstanding shares total 34.18M. The firm has a beta of 1.36. NVIV’s shares traded
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne